CVS Health Corporation $CVS Shares Bought by Ethic Inc.

Ethic Inc. grew its holdings in shares of CVS Health Corporation (NYSE:CVS) by 1.5% in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 33,551 shares of the pharmacy operator’s stock after acquiring an additional 505 shares during the period. Ethic Inc.’s holdings in CVS Health were worth $2,298,000 as of its most recent SEC filing.

Several other large investors also recently modified their holdings of CVS. Harbor Asset Planning Inc. acquired a new stake in shares of CVS Health during the second quarter valued at about $30,000. Bell Investment Advisors Inc grew its stake in shares of CVS Health by 119.8% during the first quarter. Bell Investment Advisors Inc now owns 455 shares of the pharmacy operator’s stock valued at $31,000 after acquiring an additional 248 shares in the last quarter. Roxbury Financial LLC grew its stake in shares of CVS Health by 78.3% during the second quarter. Roxbury Financial LLC now owns 460 shares of the pharmacy operator’s stock valued at $32,000 after acquiring an additional 202 shares in the last quarter. ORG Partners LLC grew its stake in shares of CVS Health by 418.9% during the second quarter. ORG Partners LLC now owns 467 shares of the pharmacy operator’s stock valued at $32,000 after acquiring an additional 377 shares in the last quarter. Finally, Saudi Central Bank acquired a new stake in shares of CVS Health during the first quarter valued at about $34,000. 80.66% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

CVS has been the subject of a number of research reports. Wall Street Zen upgraded CVS Health from a “hold” rating to a “buy” rating in a research note on Sunday, September 21st. Truist Financial set a $92.00 price target on CVS Health in a research note on Tuesday, October 14th. Barclays lifted their price target on CVS Health from $80.00 to $87.00 and gave the stock an “overweight” rating in a research note on Thursday, September 4th. Robert W. Baird upgraded CVS Health from a “neutral” rating to an “outperform” rating and lifted their price target for the stock from $71.00 to $82.00 in a research note on Thursday, August 14th. Finally, Wolfe Research lifted their price target on CVS Health from $80.00 to $85.00 and gave the stock an “outperform” rating in a research note on Monday, September 22nd. Two equities research analysts have rated the stock with a Strong Buy rating, twenty have issued a Buy rating and four have given a Hold rating to the company. Based on data from MarketBeat.com, CVS Health has a consensus rating of “Moderate Buy” and an average price target of $83.38.

CVS Health Stock Performance

Shares of NYSE CVS opened at $81.95 on Friday. The company has a quick ratio of 0.62, a current ratio of 0.80 and a debt-to-equity ratio of 0.74. The firm’s 50-day moving average price is $75.57 and its two-hundred day moving average price is $68.67. CVS Health Corporation has a 52-week low of $43.56 and a 52-week high of $83.52. The stock has a market capitalization of $103.94 billion, a P/E ratio of 22.89, a P/E/G ratio of 0.89 and a beta of 0.60.

CVS Health (NYSE:CVS) last issued its earnings results on Thursday, July 31st. The pharmacy operator reported $1.81 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.46 by $0.35. CVS Health had a net margin of 1.17% and a return on equity of 10.51%. The firm had revenue of $98.92 billion for the quarter, compared to analysts’ expectations of $94.87 billion. During the same quarter last year, the company posted $1.83 earnings per share. CVS Health’s revenue was up 8.4% on a year-over-year basis. CVS Health has set its FY 2025 guidance at 6.300-6.400 EPS. As a group, sell-side analysts forecast that CVS Health Corporation will post 5.89 earnings per share for the current year.

CVS Health Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Monday, November 3rd. Stockholders of record on Thursday, October 23rd will be issued a dividend of $0.665 per share. This represents a $2.66 dividend on an annualized basis and a dividend yield of 3.2%. The ex-dividend date of this dividend is Thursday, October 23rd. CVS Health’s payout ratio is 74.30%.

Insider Buying and Selling at CVS Health

In other news, Director Anne A. Finucane sold 7,500 shares of CVS Health stock in a transaction that occurred on Wednesday, August 20th. The stock was sold at an average price of $71.02, for a total transaction of $532,650.00. Following the sale, the director owned 22,156 shares of the company’s stock, valued at approximately $1,573,519.12. The trade was a 25.29% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Company insiders own 1.22% of the company’s stock.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.